In this view, the aim of this study was to assess the presence of Treg cells in canine mammary carcinoma through the identification of Foxp3, their currently most reliable marker [13], and the association of Treg cells with various clinicopathological and immunohistochemical features and overall survival (OS). This evidence concerns the gene FOXP3 and breast carcinoma.